Dechra Pharmaceuticals to debut in US PPs
Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has entered the US private placement (US PP) market, according to sources, in a debut set to test institutional appetite for the sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: